1
00:00:00,000 --> 00:00:08,000
Globalcast MD, along with Cincinnati Children's Hospital, sharing knowledge to improve child health around the globe.

2
00:00:08,000 --> 00:00:14,000
Hello, pediatric surgery family. I'm Em Gootee from Cincinnati Children's Hospital Medical Center.

3
00:00:14,000 --> 00:00:19,000
Our twelfth annual update course in pediatric surgery was held past August.

4
00:00:19,000 --> 00:00:23,000
In this video series, we'll recap the sessions and share the main highlights with you.

5
00:00:23,000 --> 00:00:29,000
This year, we introduced a new approach to classify practice-changing ideas at our update course.

6
00:00:29,000 --> 00:00:32,000
Presentations now fall into three categories.

7
00:00:32,000 --> 00:00:35,000
Green Circle for established practice,

8
00:00:35,000 --> 00:00:38,000
Blue Square for promising newer practice,

9
00:00:38,000 --> 00:00:42,000
and Black Diamond for early adopter practice only.

10
00:00:42,000 --> 00:00:48,000
Here, Dr. Greg Tiaow, the Surgical Director of the Liver Transplantation Program at Cincinnati Children's,

11
00:00:48,000 --> 00:00:53,000
will explain the use of MMP7 as a diagnostic tool in biliary atresia.

12
00:00:53,000 --> 00:01:01,000
What we're going to try to touch on is a concept which is a timely diagnosis of biliary atresia is critical to prolong the native liver survival.

13
00:01:01,000 --> 00:01:07,000
The challenge, of course, that we all face is that oftentimes these kids come in late, they take a little bit of time to work up.

14
00:01:07,000 --> 00:01:16,000
As a result, we are offering surgery at later and later stages, so the key to treating biliary atresia is making an early diagnosis.

15
00:01:16,000 --> 00:01:21,000
This is where this biomarker that really came out of Georgia Bezerra's lab, my research mentor.

16
00:01:21,000 --> 00:01:28,000
He identified MMP7 about 10 years ago as a diagnostic biomarker for biliary atresia.

17
00:01:28,000 --> 00:01:34,000
And this all ties to this critical concept that I think we all know, but we don't necessarily integrate,

18
00:01:34,000 --> 00:01:37,000
which is you've got to get your casais done as soon as possible.

19
00:01:37,000 --> 00:01:42,000
The sooner and sooner you get it done, the more likely you'll save the native liver.

20
00:01:42,000 --> 00:01:48,000
So this actually was a little guy who showed up just a couple of weeks ago on our service here, a 38-day-old child.

21
00:01:48,000 --> 00:01:52,000
He has a little bit of jaundice, has meconium on the first day. He's gaining weight.

22
00:01:52,000 --> 00:01:55,000
The pediatrician says, oh, it's physiologic jaundice of a newborn.

23
00:01:55,000 --> 00:02:01,000
But then the jaundice persists, his stool is clay-colored, and his lab results are consistent with biliary atresia.

24
00:02:01,000 --> 00:02:04,000
This is when things start to escalate.

25
00:02:04,000 --> 00:02:07,000
We then refer them into a hepatologist who then starts to work up.

26
00:02:07,000 --> 00:02:13,000
And of course, they'll get an ultrasound here, and in this particular case, it had pretty classic findings for biliary atresia.

27
00:02:13,000 --> 00:02:21,000
The challenge pediatricians face is the differential diagnosis for neonatal jaundice, which includes a long list of potential causes.

28
00:02:21,000 --> 00:02:31,000
The key is to distinguish BA from other non-physiologic cholestatic jaundice conditions so that we can get our casais done at an earlier and earlier stage.

29
00:02:31,000 --> 00:02:38,000
So we have a patient like this and have an ultrasound that's suspicious for biliary atresia. What are you going to do?

30
00:02:38,000 --> 00:02:42,000
Those of us who are doing casais, what is your decision-making here?

31
00:02:42,000 --> 00:02:47,000
All of those options are actually correct, because it depends on your institution, right?

32
00:02:47,000 --> 00:02:51,000
At our institution, we stopped doing a HIDA scan about 25 years ago.

33
00:02:51,000 --> 00:02:56,000
The challenge that we face with a HIDA scan is it adds about five days to this study.

34
00:02:56,000 --> 00:03:04,000
And data from a recent Midwest study shows that for every 10-day delay in treatment, outcomes worsen by 20 percent.

35
00:03:04,000 --> 00:03:09,000
But it is one of those things where the earlier we can intervene, the better off we'll be.

36
00:03:09,000 --> 00:03:13,000
So this translates to some work that led to this MMP7 study.

37
00:03:13,000 --> 00:03:17,000
So about 10 years ago, Georgia took on some data from the Children's Network.

38
00:03:17,000 --> 00:03:25,000
Children's Network is a national consortium of about 14 centers in which all the cholestatic liver disease children were enrolled in the registry.

39
00:03:25,000 --> 00:03:35,000
And Dr. Bizarra took about 70 or so patients from that, some who had biliary atrasia, some had idiopathic cholestasis, and did some proteomics on that.

40
00:03:35,000 --> 00:03:44,000
And he screened about a thousand proteins, and they actually found 70 or so that were elevated in the BA population, of which MMP7 was the most clear.

41
00:03:44,000 --> 00:03:52,000
The challenge he faced was that, even within the Children's Network, the disease frequency is low, with only 200 to 300 cases per year.

42
00:03:52,000 --> 00:03:56,000
This made it very difficult to conduct another study for validation.

43
00:03:56,000 --> 00:04:01,000
Well, this is where he took advantage of the incidence being higher in the Far East.

44
00:04:01,000 --> 00:04:11,000
Dr. Bizarra was able to validate the findings in just two years through a study conducted in mainland China, where the frequency of biliary atrasia is much higher.

45
00:04:11,000 --> 00:04:20,000
And of course, they really strive to get those kids a Kassai very early, because if they don't, liver transplant is their only option, and it's not readily available.

46
00:04:20,000 --> 00:04:22,000
And so those kids face the mortality risk.

47
00:04:22,000 --> 00:04:27,000
So MMP7 is now a validated biomarker for biliary atrasia.

48
00:04:27,000 --> 00:04:39,000
It's not perfect. And actually, if you just look on the table here, the sensitivity is pretty good, but the cutoffs that the different teams used vary, because it's an assay that's still evolving in front of our eyes, and depending on how you do it.

49
00:04:39,000 --> 00:04:44,000
This all leads to the next important question. When will you perform the Kassai procedure?

50
00:04:44,000 --> 00:04:52,000
Our commitment to the patients who come to our institution is within seven days of them showing up, if they have it, they're in the OR.

51
00:04:52,000 --> 00:05:03,000
Here is a study from the Children's Network, in which they showed that the average date of a biliary atrasia patient going through a Kassai in North America was around 75 days.

52
00:05:03,000 --> 00:05:13,000
This one came from Europe, where they actually showed that if you did your Kassai before 45 days, you'd actually reduce the incidence of transplant need in that patient population.

53
00:05:13,000 --> 00:05:22,000
All of this is driving the integration of MMP7 into the diagnostic process, allowing for earlier diagnosis and getting patients to a Kassai procedure as soon as possible.

54
00:05:22,000 --> 00:05:28,000
And this is really the last point, which is a Kassai pornoasomy done before 45 days is the goal.

55
00:05:28,000 --> 00:05:37,000
We actually will do it before 30 days if we can establish a diagnosis, because nowadays more and more nurseries are screening their kids at discharge.

56
00:05:37,000 --> 00:05:45,000
And if you have a direct biliary ribbon over one in the newborn period, that's also very sensitive for biliary atrasia, so those kids get plugged into GIT sooner and sooner.

57
00:05:45,000 --> 00:05:54,000
In conclusion, timely diagnosis of biliary atrasia is vital for native liver survival, as early intervention through the Kassai procedure greatly improves outcomes.

58
00:05:54,000 --> 00:06:02,000
MMP7 has been validated as a biomarker to aid in earlier diagnosis, though its assay continues to evolve.

59
00:06:02,000 --> 00:06:14,000
Research highlights the importance of performing the Kassai procedure within 45 days, with some institutions striving for a 30-day target to reduce the need for transplants and enhance survival rates.

60
00:06:14,000 --> 00:06:33,000
Thank you for watching this video.